UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The FOxTROT platform: Clinical trials and exploratory research for personalization of neoadjuvant (NA) therapy in locally advanced colon cancer (LACC)—ISRCTN83842641

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS3636-TPS3636

2023

Volltextzugriff (PDF)

PRIMUS-002: A multicentre, open-label, phase II study examining FOLFOX and nab-paclitaxel (FA) and nab-paclitaxel and gemcitabine (AG) as neoadjuvant therapy for (borderline) resectable pancreatic cancer (PC), focusing on biomarker and liquid biopsy development

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.669-669

2024

Volltextzugriff (PDF)

NuTide:302: A phase Ib study to assess the safety, pharmacokinetics and clinical activity of the ProTide NUC-3373 when combined with standard agents used in colorectal cancer

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.TPS719-TPS719

2019

Volltextzugriff (PDF)

Systemic inflammation, adjuvant chemotherapy, and survival in stage III colorectal cancer: Results from the ScotScan Colorectal Cancer Collaborative

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.228-228

2020

Volltextzugriff (PDF)

NuTide: 302—A phase Ib study of the ProTide NUC-3373 in combination with standard therapies in advanced colorectal cancer

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.TPS274-TPS274

2020

Volltextzugriff (PDF)

Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors

Clinical colorectal cancer, 2021-12, Vol.20 (4), p.342-349

2021

Volltextzugriff (PDF)

Real-world experience of trifluridine/tipiracil in patients with metastatic colorectal cancer: A multicenter United Kingdom study

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.668-668

2019

Volltextzugriff (PDF)

Prospective DPYD testing and dose adjustment in colorectal cancer patients prior to fluoropyrimidine-based chemotherapy: Experience in a regional cancer center

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.93-93

2020

Volltextzugriff (PDF)

Prognostic phenotypic subtypes to predict recurrence and response to adjuvant chemotherapy for colorectal cancer

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.205-205

2020

Volltextzugriff (PDF)

PRIMUS-001: An adaptive phase II study of FOLFOX-A (FOLFOX and nab -paclitaxel) versus AG ( nab -paclitaxel and gemcitabine) in patients with metastatic pancreatic cancer, with integrated biomarker evaluation (ISRCTN75002153) – Part of Precision-Panc

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.TPS4158-TPS4158

2018

Volltextzugriff (PDF)

PRIMUS-002: A multicentre, open-label, phase II study examining FOLFOX and nab -paclitaxel (FA) and nab -paclitaxel and gemcitabine (AG) as neoadjuvant therapy for (borderline) resectable pancreatic cancer (PC), focusing on biomarker and liquid biopsy development

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.TPS4166-TPS4166

2019

Volltextzugriff (PDF)

Aspirin as adjuvant treatment for colorectal cancer: Rationale and progress of the Add-Aspirin trial

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.TPS3624-TPS3624

2019

Volltextzugriff (PDF)

FOLFIRINOX chemotherapy in locally advanced and metastatic pancreatic adenocarcinoma: A retrospective analysis of toxicity and outcomes

Journal of clinical oncology, 2015-01, Vol.33 (3_suppl), p.436-436

2015

Volltextzugriff (PDF)

Randomized phase II trial comparing the efficacy and safety of nintedanib versus sorafenib in patients with advanced hepatocellular carcinoma (HCC)

Journal of clinical oncology, 2015-01, Vol.33 (3_suppl), p.238-238

2015

Volltextzugriff (PDF)

GLOBAL BALLAD: An International Rare Cancers Initiative trial to evaluate the potential benefit of adjuvant chemotherapy for small bowel adenocarcinoma (IRCI 002)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.TPS4154-TPS4154

2016

Volltextzugriff (PDF)

Role of neoadjuvant treatment regimens for locally advanced pancreatic cancer

Journal of clinical oncology, 2015-01, Vol.33 (3_suppl), p.444-444

2015

Volltextzugriff (PDF)

Efficacy and safety of nintedanib (N) versus sorafenib (S) in Caucasian and Asian patients with advanced hepatocellular carcinoma (HCC): Pooled analysis of two randomized phase II trials

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.4074-4074

2015

Volltextzugriff (PDF)

Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy

The New England journal of medicine, 2017-11, Vol.377 (18), p.1723-1732

2017

Volltextzugriff (PDF)

Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy

The New England journal of medicine, 2018-02, Vol.378 (7), p.625-635

2018

Volltextzugriff (PDF)

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2018-02, Vol.391 (10121), p.668-678

2018

Volltextzugriff (PDF)

Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicity

PloS one, 2010-08, Vol.5 (8), p.e11995

2010

Volltextzugriff (PDF)

Relationships among the confounding genera Ammannia, Hionanthera, Nesaea and Rotala (Lythraceae)

Botanical journal of the Linnean Society, 2011-05, Vol.166 (1), p.1-19

2011

Volltextzugriff (PDF)

expanded phylogeny of Cuphea (Lythraceae) and a North American monophyly

Plant systematics and evolution, 2010-10, Vol.289 (1-2), p.35-44

2010

Volltextzugriff (PDF)

Associations between hyperopia and other vision and refractive error characteristics

Optometry and vision science, 2014-04, Vol.91 (4), p.383-389

2014

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The FOxTROT platform: Clinical trials and exploratory research for personalization of neoadjuvant (NA) therapy in locally advanced colon cancer (LACC)—ISRCTN83842641

PRIMUS-002: A multicentre, open-label, phase II study examining FOLFOX and nab-paclitaxel (FA) and nab-paclitaxel and gemcitabine (AG) as neoadjuvant therapy for (borderline) resectable pancreatic cancer (PC), focusing on biomarker and liquid biopsy development

NuTide:302: A phase Ib study to assess the safety, pharmacokinetics and clinical activity of the ProTide NUC-3373 when combined with standard agents used in colorectal cancer

Systemic inflammation, adjuvant chemotherapy, and survival in stage III colorectal cancer: Results from the ScotScan Colorectal Cancer Collaborative

NuTide: 302—A phase Ib study of the ProTide NUC-3373 in combination with standard therapies in advanced colorectal cancer

Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors

Real-world experience of trifluridine/tipiracil in patients with metastatic colorectal cancer: A multicenter United Kingdom study

ESPAC-5F: Four-arm, prospective, multicenter, international randomized phase II trial of immediate surgery compared with neoadjuvant gemcitabine plus capecitabine (GEMCAP) or FOLFIRINOX or chemoradiotherapy (CRT) in patients with borderline resectable pancreatic cancer

Prospective DPYD testing and dose adjustment in colorectal cancer patients prior to fluoropyrimidine-based chemotherapy: Experience in a regional cancer center

Prognostic phenotypic subtypes to predict recurrence and response to adjuvant chemotherapy for colorectal cancer

PRIMUS-001: An adaptive phase II study of FOLFOX-A (FOLFOX and nab -paclitaxel) versus AG ( nab -paclitaxel and gemcitabine) in patients with metastatic pancreatic cancer, with integrated biomarker evaluation (ISRCTN75002153) – Part of Precision-Panc

PRIMUS-002: A multicentre, open-label, phase II study examining FOLFOX and nab -paclitaxel (FA) and nab -paclitaxel and gemcitabine (AG) as neoadjuvant therapy for (borderline) resectable pancreatic cancer (PC), focusing on biomarker and liquid biopsy development

Aspirin as adjuvant treatment for colorectal cancer: Rationale and progress of the Add-Aspirin trial

FOLFIRINOX chemotherapy in locally advanced and metastatic pancreatic adenocarcinoma: A retrospective analysis of toxicity and outcomes

Randomized phase II trial comparing the efficacy and safety of nintedanib versus sorafenib in patients with advanced hepatocellular carcinoma (HCC)

GLOBAL BALLAD: An International Rare Cancers Initiative trial to evaluate the potential benefit of adjuvant chemotherapy for small bowel adenocarcinoma (IRCI 002)

Role of neoadjuvant treatment regimens for locally advanced pancreatic cancer

Efficacy and safety of nintedanib (N) versus sorafenib (S) in Caucasian and Asian patients with advanced hepatocellular carcinoma (HCC): Pooled analysis of two randomized phase II trials

Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy

Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial

Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicity

Relationships among the confounding genera Ammannia, Hionanthera, Nesaea and Rotala (Lythraceae)

expanded phylogeny of Cuphea (Lythraceae) and a North American monophyly

Associations between hyperopia and other vision and refractive error characteristics

Suchergebnisse filtern